Trends of pulmonary fungal infections from 2013 to 2019: an AI-based real-world observational study in Guangzhou, China

ABSTRACT Recently, the prevalence trend of pulmonary fungal infection (PFI) has rapidly increased. Changes in the risk factors for, distributions of underlying diseases associated with and clinical characteristics of some individual PFIs have been reported in the past decade. However, data regarding PFIs remain uncertain. This study reports the epidemiological characteristics and trends of PFIs over time in recent years. We applied an automated natural language processing (NLP) system to extract clinically relevant information from the electronic health records (EHRs) of PFI patients at the First Affiliated Hospital of Guangzhou Medical University. Then, a trend analysis was performed. From January 1, 2013, to December 31, 2019, 40,504 inpatients and 219,414 outpatients with respiratory diseases were screened, in which 1368 inpatients and 1313 outpatients with PFI were identified. These patients were from throughout the country, but most patients were from southern China. Upward trends in PFIs were observed in both hospitalized patients and outpatients (P<0.05). The stratification by age showed that the incidence of hospitalized patients aged 14–30 years exhibited the most obvious upward trend, increasing from 9.5 per 1000 patients in 2013 to 88.3 per 1000 patients in 2019. Aspergillosis (56.69%) was the most common PFI, but notably, the incidence rates of Talaromyces marneffei, which used to be considered uncommon, exhibited the most rapid increases. In younger PFI patients, the incidence and trend of PFIs have increased. Infection by previously uncommon pathogens has also gradually increased. Increased attention should be paid to young PFI patients and uncommon PFI pathogen infections.

[1]  J. Perfect,et al.  Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Latgé,et al.  Aspergillus fumigatus and Aspergillosis in 2019 , 2019, Clinical Microbiology Reviews.

[3]  M. Murad,et al.  Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice. An Official American Thoracic Society Clinical Practice Guideline , 2019, American journal of respiratory and critical care medicine.

[4]  A. Beauvais,et al.  Interactions between Aspergillus fumigatus and Pulmonary Bacteria: Current State of the Field, New Data, and Future Perspective , 2019, Journal of fungi.

[5]  P. Visca,et al.  Aspergillus-Pseudomonas interaction, relevant to competition in airways. , 2019, Medical mycology.

[6]  M. Antonelli,et al.  ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients , 2019, Intensive Care Medicine.

[7]  M. Gwinn,et al.  Next-Generation Sequencing of Infectious Pathogens. , 2019, JAMA.

[8]  Daniel S. Kermany,et al.  Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence , 2019, Nature Medicine.

[9]  E. Andrinopoulou,et al.  Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. , 2018, The Lancet. Respiratory medicine.

[10]  B. Nathanson,et al.  Epidemiology and Outcomes of Hospitalizations With Invasive Aspergillosis in the United States, 2009–2013 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  C. Mody,et al.  Epidemiology and trends of cryptococcosis in the United States from 2000 to 2007: A population-based study , 2018, International journal of STD & AIDS.

[12]  Liang Ma,et al.  New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China , 2018, Infection and drug resistance.

[13]  E. Castañeda,et al.  Cryptococcosis in Colombia: Compilation and Analysis of Data from Laboratory-Based Surveillance , 2018, Journal of fungi.

[14]  M. Martínez-García,et al.  Fungi in Bronchiectasis: A Concise Review , 2018, International journal of molecular sciences.

[15]  D. Denning,et al.  Pulmonary and sinus fungal diseases in non-immunocompromised patients. , 2017, The Lancet. Infectious diseases.

[16]  Karen C Carroll,et al.  Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  W. Powderly,et al.  Cryptococcosis Today: It Is Not All About HIV Infection , 2017, Current Clinical Microbiology Reports.

[18]  H. Einsele,et al.  ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. , 2016, The Journal of antimicrobial chemotherapy.

[19]  J. Latgé,et al.  Volatile Compounds Emitted by Pseudomonas aeruginosa Stimulate Growth of the Fungal Pathogen Aspergillus fumigatus , 2016, mBio.

[20]  P. Woo,et al.  Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients , 2016, Emerging Microbes & Infections.

[21]  D. Denning,et al.  British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. , 2015, The Lancet. Infectious diseases.

[22]  S. Xiong,et al.  [A multicentre retrospective study of pulmonary mycosis clinically proven from 1998 to 2007]. , 2011, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[23]  A. Limper The changing spectrum of fungal infections in pulmonary and critical care practice: clinical approach to diagnosis. , 2010, Proceedings of the American Thoracic Society.

[24]  E. van Wijngaerden,et al.  Invasive aspergillosis in the intensive care unit. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Richard W. Grant,et al.  Case Report: Using Regular Expressions to Abstract Blood Pressure and Treatment Intensification Information from the Text of Physician Notes , 2006, J. Am. Medical Informatics Assoc..

[26]  T. Sirisanthana,et al.  Penicillium marneffei Infection and Recent Advances in the Epidemiology and Molecular Biology Aspects , 2006, Clinical Microbiology Reviews.

[27]  Marion J. Ball,et al.  Healthcare Information Management Systems: Cases, Strategies, and Solutions , 2004, Health Informatics.

[28]  C. Kauffman,et al.  Pulmonary fungal infections , 2012, Respirology.

[29]  P. Hsueh,et al.  Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. , 2001, Chest.

[30]  P. Goryński,et al.  Epidemiology of Pulmonary Aspergillosis in Hospitalized Patients in Poland During 2009-2016. , 2019, Advances in experimental medicine and biology.

[31]  The Lancet Child & Adolescent Health Cancer in the young: progress and priorities. , 2018, The Lancet. Child & adolescent health.

[32]  Jianying Hu,et al.  Data Driven Analytics for Personalized Healthcare , 2016 .

[33]  J. Mensa,et al.  [Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease]. , 2014, Revista iberoamericana de micologia.

[34]  N. Ampel,et al.  An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. , 2011, American journal of respiratory and critical care medicine.

[35]  K. Engels,et al.  Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. , 2010, The Journal of infection.